Protia Inc

A-702, 401 Yangcheon-Ro, Gangseo-Gu, Seoul 07528, Republic of Korea
Seoul,  07528

Korea (South)
https://www.protia.co.kr/en

• Booth: 4346

ProteomeTech Inc. provides several innovative IVD products with its own patented technology and provides proteomics-based biomarker research in goal of giving substantial benefits to the customer. PROTIA Allergy-Q, allergy test detecting over 100 allergies in one panel; ImmuneCheck IgG, Human IgG rapid test can get semi-quantitative results; PROTIA food IgG detecting over 60 food specific IgG, showing food Intolerance. Other innovative IVD products for human and animals are ready to provide

 Press Releases

• PROTIA Antimicrobial Susceptibility Test (AST) (Jul 29, 2024)
  PROTIA Inc.
  
  Booth number
   4346
  
  Description
   The PROTIA AST DL001 plates use a patented biosensor to measure electrical capacitance for testing antibiotic susceptibility. The Q-AST 192 Pro equipment is a fully automated equipment with an intuitive UI, providing test results in at least 3.5 hours.
  For more information of the PROTIA AST DL001 test concept: A sample is placed on an antibiotic coated plate and cultured. Electrical capacitance is measured every 15 minutes, if the bacteria are resistance, they will proliferate as the antibiotic fails to inhibit growth, resulting in an increase in electrical capacitance. Conversely, if the bacteria are susceptible, growth is inhibited, resulting in minimal change in capacitance. All electrical capacitance measurements are processed by the PROTIA AST algorithm embedded in the internal PC of the Q-AST 192 Pro equipment.

• PROTIA Autoimmune diseases diagnostic test (Jul 29, 2024)
  PROTIA Inc.
  
  Booth number
   4346
  Description
   PROTIA ANA (Anti-nuclear Antibody) Profile 18 is an in vitro diagnostic test in the quantitative determination of auto-antigen-specific IgG concentrations in human serum and plasma.
  Typical systemic auto-immune diseases include systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Systemic Sclerosis (SSc), Myositis, and Mixed connective Tissue Disease (MCTD) and each disease produces an autoantibody against a specific various autoantigen. Therefore, it helps diagnose and treat patients that the measurement of various auto-antigen-specific IgG antibodies including anti-nuclear antibodies, in patients suspected of systemic auto-immune disease.

• PROTIA Allergy-Q (Jul 29, 2024)
  PROTIA Inc.
  
  Booth number
   4346
  Description
   PROTIA Allergy-Q utilizes an immunoassay method to test for up to 118 types of specific IgE (Allergen) which cause of allergy. We plan to release products that can test for 122 and 178 types of allergens, using PROTIA's patented parallel line array technology.
  This allows for the testing the maximum number of allergens with a minimal strip size, thereby reducing the amount of sample, time, and cost required for testing.
  Additionally, the Allergy-Q 128M product, which can test for 118 types of allergens, requires only 150 μL of human serum or plasma, making it suitable for pediatric use. The panel itself includes a calibration lines, ensuring consistent results under various condition.
  Additionally, this year we have launched an allergy testing panel specifically for Middle Eastern countries, PROTIA Allergy-Q 64G. We also offer a variety of panels for Atopy and Food Intolerance test.